Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Citi
Fuji
Chinese Patent Office
Deloitte
Cerilliant
Julphar
UBS
Dow
Daiichi Sankyo
Express Scripts

Generated: August 20, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020799

« Back to Dashboard
NDA 020799 describes FLOXIN OTIC, which is a drug marketed by Daiichi and is included in one NDA. Additional details are available on the FLOXIN OTIC profile page.

The generic ingredient in FLOXIN OTIC is ofloxacin. There are seventy drug master file entries for this compound. Thirty-three suppliers are listed for this compound. Additional details are available on the ofloxacin profile page.

Summary for NDA: 020799

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details

Summary for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:SOLUTION/DROPS;OTICStrength0.3% **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Approval Date:Dec 16, 1997TE:RLD:Yes

Expired Orange Book Patents for NDA: 020799

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Daiichi
FLOXIN OTIC
ofloxacin
SOLUTION/DROPS;OTIC020799-001Dec 16, 1997► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

AstraZeneca
Julphar
Johnson and Johnson
Covington
Deloitte
Farmers Insurance
Healthtrust
Daiichi Sankyo
Queensland Health
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot